DIA 2017 Annual Meeting
June 18-22, 2017
McCormick Place | Chicago, IL
The DIA 2017 Annual Meeting is the largest, longest-running event in the life sciences industry designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies. DIA 2017, themed “Driving Insights to Action,” will host more than 7,000 global health care professionals in the pharmaceutical, biotechnology, and medical device communities from more than 51 countries. In its 53rd year, DIA 2017 will hold more than 160 sessions over 10+ tracks and bring in more than 450 exhibiting companies.
Tuesday, June 20, 2017 | 4:00PM – 5:15PM | Room N426b
#283 Track 8 – Strategic Planning/Execution and Partnerships – The Impact of Industry Consortia on Creating Collaborative Solutions to Drug Development Challenges: What Does the Future Hold?
Patricia Leuchten, President and CEO, The Avoca Group
Industry Consortia are Propelling Collaborative, Creative Solutions in Drug Development: How Have We Enabled Partnering Between Sponsors, CROs, and Other Industry Stakeholder Groups to Foster Change and Create Streamlined Solutions?
Steven B. Whittaker
Executive Director, Quality Consortium, The Avoca Group
Change Management Requires Processes, Technology, AND PEOPLE: A New Paradigm in Innovative Workforce Development Through Previously Unused Forms of Collaboration
Executive Director, Association of Clinical Research Professionals (ACRP)
Industry-Based GCP, GLP, GMP, and Nonregulated Outsourcing Oversight Maturity Model: Partnering on Solutions to Reduce the Gap Between Sponsors and CROs
Barbara Kristina Beck, MS
Director, Written Standards and Governance, Third Party Resourcing, GlaxoSmithKline